Dyne Therapeutics, Inc. DYN Other Operating Income Expense Net
Other Operating Income Expense Net at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s other operating income expense net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s other operating income expense net?
- Dyne Therapeutics, Inc. (DYN) reported other operating income expense net of -$133K in Q1 2026.
- How has Dyne Therapeutics, Inc.'s other operating income expense net changed year-over-year?
- Dyne Therapeutics, Inc.'s other operating income expense net decreased by 49.4% year-over-year, from -$89K to -$133K.
- What is the long-term trend for Dyne Therapeutics, Inc.'s other operating income expense net?
- Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s other operating income expense net has grown at a 281.6% compound annual growth rate (CAGR), from -$8K to -$1.7M.